Whitehawk Therapeutics (WHWK) lists 775,828 RSUs; recent 5,100-share sale
Rhea-AI Filing Summary
Whitehawk Therapeutics submitted a Form 144 notice covering proposed sales of Common Stock and Restricted Stock Units.
The filing lists 775,828 Restricted Stock Units with an entry date of 04/01/2026 and reports a prior sale of 5,100 shares on 03/02/2026 for $16,878.96.
Positive
- None.
Negative
- None.
Insights
Form 144 records proposed resale activity and a recent small open-market sale.
Form 144 is a regulatory notice used to report proposed sales by affiliates or insiders. The filing here lists 775,828 Restricted Stock Units dated 04/01/2026 and a reported sale of 5,100 shares on 03/02/2026 for $16,878.96. This reflects routine disclosure obligations rather than an executed large distribution.
Timing and exact planned methods for resale are not provided in the excerpt; subsequent filings may detail sale mechanics or confirm execution. Cash‑flow treatment is not specified in the provided excerpt.